Author

A.-M. Ferreira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:flow cytometry· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. A. Blish· 2 shared N. Q. Zhao· 2 shared C. Seiler· 1 shared E. Vendrame· 1 shared J. D. Fontenot· 1 shared L. J. Simpson· 1 shared P. M. Grant· 1 shared S. Holmes· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. A. Blish

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivApr 12, 2020

Treated HIV Infection Alters Phenotype But Not HIV-specific Function of Peripheral Blood Natural Killer Cells

N. Q. Zhao, A.-M. Ferreira, P. M. Grant…·C. A. Blish

This study examines how treated HIV infection affects NK cell phenotype and function, finding altered repertoires but no increased HIV-specificity.

DOI 10.3389/fimmu.2020.00829

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivDec 5, 2019

Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry

T. Ranganath, L. J. Simpson, C. Seiler…·C. A. Blish

This study uses mass cytometry to analyze how daclizumab beta affects NK cell phenotypes in RMS patients, showing distinct changes in CD56bright and CD56dim subsets.

DOI 10.3389/fimmu.2020.00714

humanflow cytometry

𝕏 PostBluesky